Conversion from calcineurin inhibitors to sirolimus versus continued use of calcineurin inhibitors in renal allograft recipients: 18-month efficacy and safety results from a large, randomized, open-label, comparative trial

被引：0
|
作者：
Pussell, B [1 ]
Russ, G [1 ]
Walker, R [1 ]
Campbell, S [1 ]
O'Connell, P [1 ]
Kanellis, J [1 ]
Eris, J [1 ]
机构：
[1] Prince Wales Hosp, Dept Nephrol, Randwick, NSW 2031, Australia
来源：
IMMUNOLOGY AND CELL BIOLOGY | 2006年 / 84卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：A19 / A20
页数：2
相关论文
共 50 条
  • [1] CONVERSION FROM CALCINEURIN INHIBITORS TO SIROLIMUS VERSUS CONTINUED USE OF CALCINEURIN INHIBITORS IN RENAL ALLOGRAFT RECIPIENTS: A RANDOMIZED, OPEN-LABEL, COMPARATIVE TRIAL
    Vathsala, A.
    Schena, Francesco P.
    Wali, Ravinder K.
    Pascoe, Michael D.
    Alberu, Josefina
    Del Carmen Rial, Maria
    NEPHROLOGY, 2005, 10 : A217 - A217
  • [2] A randomized, open-label, comparative evaluation of conversion from calcineurin inhibitors to sirolimus versus continued use of calcineurin inhibitors in renal allograft recipients
    Schena, FP
    Wali, RK
    Pascoe, MD
    Alberu, J
    Rial, MD
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 413 - 413
  • [3] EFFICACY AND SAFETY OF CONVERSION FROM CALCINEURIN INHIBITORS TO SIROLIMUS VERSUS CONTINUED USE OF CALCINEURIN INHIBITORS IN RENAL ALLOGRAFT RECIPIENTS: RESULTS OF THE CONVERT TRIAL
    Pussell, B.
    Russ, G.
    Walker, R.
    Campbell, S.
    O'Connell, P.
    Kanellis, J.
    Eris, J.
    NEPHROLOGY, 2006, 11 : A35 - A35
  • [4] Sirolimus Conversion Regimen Versus Continued Calcineurin Inhibitors in Liver Allograft Recipients: A Randomized Trial
    Abdelmalek, M. F.
    Humar, A.
    Stickel, F.
    Andreone, P.
    Pascher, A.
    Barroso, E.
    Neff, G. W.
    Ranjan, D.
    Toselli, L. T.
    Gane, E. J.
    Scarola, J.
    Alberts, R. G.
    Maller, E. S.
    Lo, C. -M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (03) : 694 - 705
  • [5] Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial
    Schena, Francesco P.
    Pascoe, Michael D.
    Alberu, Josefina
    del Carmen Rial, Maria
    Oberbauer, Rainer
    Brennan, Daniel C.
    Campistol, Josep M.
    Racusen, Lorraine
    Polinsky, Martin S.
    Goldberg-Alberts, Robert
    Li, Huihua
    Scarola, Joseph
    Neylan, John F.
    TRANSPLANTATION, 2009, 87 (02) : 233 - 242
  • [6] An open-label, pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in established renal allograft recipients with moderate renal insufficiency
    Peddi, VR
    Jensik, S
    Pescovitz, M
    Pirsch, J
    Adler, SH
    Thistlethwaite, JR
    Vincenti, F
    Cohen, DJ
    CLINICAL TRANSPLANTATION, 2005, 19 (01) : 130 - 136
  • [7] A Randomized, Open-Label Study To Compare the Safety and Efficacy of Conversion From a Calcineurin Inhibitor (CNI) to Sirolimus Versus Continued Use of a CNI in Cardiac Transplant Recipients with Mild to Moderate Renal Insufficiency
    Zuckermann, A.
    Keogh, A.
    Crespo-Leiro, M. G.
    Mancini, D.
    Gonzalez-Vilchez, F.
    Almenar, L.
    Brozena, S.
    Eisen, H.
    Tai, S. See
    Kashwaha, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02): : S85 - S85
  • [8] An open-label, pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in established renal allograft recipients on maintenance therapy with moderate renal insufficiency
    Peddi, VR
    Cohen, DJ
    First, MR
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 364A - 364A
  • [9] Conversion from calcineurin inhibitors to sirolimus in patients with chronic renal allograft dysfunction
    Fischereder, M.
    Graeb, C.
    Krueger, B.
    Kammerl, M. C.
    Zuelke, C.
    Jauch, K. W.
    Kraemer, B. K.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (05) : 1295 - 1297
  • [10] THE SAFETY AND EFFICACY OF CONVERSION FROM CALCINEURIN INHIBITORS TO mTOR INHIBITORS IN STABLE KIDNEY TRANSPLANT RECIPIENTS
    Asanga, Abeyaratne
    Michael, Collins
    Kym, Bannister
    Graeme, Russ
    IMMUNOLOGY AND CELL BIOLOGY, 2012, 90 (08): : A1 - A1
12345